KAKKAR RAHUL (Chief Executive Officer) reported 2 transactions at PANDION THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/1/2021ACC: 0000899243-21-014453
DirectorOfficer· Chief Executive Officer
Since Jul 2020
-1.29M
Net shares
Net seller
$42.99M
Total sold
0
Open market trades
0B · 0S
4
Total transactions
1.29M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−14K
Price / share
$60.00
Trade value
$840K
% of position
New position
4/1/2021
14K→0.00
Common Stock
Indirect
Shares
−702.51K
Price / share
$60.00
Trade value
$42.15M
% of position
New position
4/1/2021
702.51K→0.00
Total
Net shares
−716.51K
Net value
-$42.99M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2021 | U · U | −14K | $60.00 | $840K | New position | 14K | 0.00 |
| Common Stock Indirect | 4/1/2021 | U · U | −702.51K | $60.00 | $42.15M | New position | 702.51K | 0.00 |
| Total | −716.51K | -$42.99M | ||||||
Derivative Transactions2
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
348.74K shares
Shares
−348.74K
Strike price
18.00
Held after
0.00
Exercisable
—
4/1/2021
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
221.37K shares
Shares
−221.37K
Strike price
17.75
Held after
0.00
Exercisable
—
4/1/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock348.74K shares | 4/1/2021 | D · Disposition | −348.74K | 18.00 | — | 0.00 |
| Employee Stock Option (Right to Buy) Direct | Common Stock221.37K shares | 4/1/2021 | D · Disposition | −221.37K | 17.75 | — | 0.00 |